Ryali Sriram 4
4 · Caribou Biosciences, Inc. · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Option to purchase Common Stock
2025-01-10+300,000→ 300,000 totalExercise: $1.64Exp: 2035-01-09→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on January 2, 2026, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following January 2, 2026), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.